(Reuters) – AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, showed an average efficiency of 70% in protecting against the virus in two study segments.
(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Shounak Dasgupta)
